Form 4: ACM Research Executive Sells $1.58M in Planned Trades
Statement of Changes in Beneficial Ownership
Sotheara Cheav, Senior VP of Manufacturing for ACM Research's Shanghai subsidiary, exercised options and sold 18,750 shares under a pre-arranged trading plan.
Summary
- Sotheara Cheav exercised stock options for a total of 18,750 Class A Common Stock shares at an exercise price of $13.89 per share.
- The reporting person sold all 18,750 exercised shares across two days, June 4 and June 5, 2026.
- Sale prices on June 4 ranged from $83.61 to $86.19 per share.
- Sale prices on June 5 ranged from $81.22 to $85.72 per share.
- The total gross proceeds from the sales amounted to approximately $1,581,000.
- Following these transactions, the reporting person still directly owns 100,002 shares of Class A Common Stock and holds 37,500 remaining stock options.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; while it involves insider selling, the trades were pre-planned and the executive maintains a substantial equity position.
Positives
- Transactions were conducted under a Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading accusations.
- The executive retains a significant ownership stake of 100,002 shares, suggesting continued alignment with shareholder interests.
- The exercise price of $13.89 compared to sale prices above $80 indicates substantial value creation and stock price appreciation since the options were granted.
Negatives
- The executive liquidated 100% of the shares exercised in this period, which could be interpreted as a lack of desire to increase their net long position.
- The sales occurred at a time when the stock was trading in the $81-$85 range, potentially signaling a perceived local peak by the executive.
Risks
- Potential for negative market sentiment following insider sales, even if planned.
- Concentration of manufacturing leadership in the Shanghai subsidiary may pose geopolitical or regional operational risks.
Future Outlook
The use of a Rule 10b5-1 plan suggests a structured approach to liquidity and diversification by the executive, with no specific forward-looking guidance provided in this regulatory filing.
Management Comments
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth upon request.
Industry Context
StockSavvy.ai notes that in the highly cyclical semiconductor equipment industry, executives frequently use automated trading plans to manage personal wealth and tax obligations without triggering market volatility or regulatory scrutiny.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is a standard best practice among executives at peer companies like Lam Research and Applied Materials.
- The retention of over 100,000 shares post-sale is consistent with typical executive ownership requirements for mid-cap technology firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan Execution | Execution of trades under a pre-established trading plan to ensure compliance with SEC anti-fraud rules. | 2026-06-04 | Positive impact on governance by reducing the risk of opportunistic insider trading. |
Stakeholder Impact
- Shareholders may see minor downward pressure on the stock price due to the increased supply of shares in the open market.
- The executive achieves personal financial diversification and liquidity.
Next Steps
- Monitor for further Form 4 filings to see if other executives are selling under similar plans.
- Observe the stock price reaction to the liquidation of these 18,750 shares.
Key Dates
| Date | Description |
|---|---|
| 2026-03-05 | Reporting person adopted the Rule 10b5-1 trading plan. |
| 2026-06-04 | Exercise of 13,351 options and subsequent sale of shares. |
| 2026-06-05 | Exercise of 5,399 options and subsequent sale of shares. |
Recommendation
holdThe insider selling is routine and planned, and the executive remains heavily invested in the company, suggesting no immediate cause for alarm regarding the company's fundamental health.
Keywords
ACMR, ACM Research, Insider Selling, Stock Options, Rule 10b5-1, Semiconductor Equipment, Sotheara Cheav, Shanghai Manufacturing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.